This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

14th Annual Pharma Regulatory Affairs
Watch On-Demand
Digital Forum | Available On-Demand

Dr Lakshmikanth Maddela
Deputy GM at Daewoong Pharmaceutical


Lakshmikanth Maddela is qualified regulatory professional with Regulatory Affairs Certification (RAC), RAPS, USA. Since 2006, he gained multi-functional experience in Regulatory Affairs, Research & Development, Quality Management, Project Management and Business Development. As a proven leader in multiple functionalities, he has in-depth expertise in designing strategic solutions, risk assessment & management, product life cycle management at regional and international level. He has been also an invited speaker in various regulatory affairs events.

He earned Ph.D. degree in Chemistry from Mewar University (India), Master of Science degree in Chemistry from Andhra university (India) and Master of Business Administration degree from SGV University (India). He has been for over 9 years with Daewoong Pharmaceutical, India; and responsible for Research & Development, Regulatory (domestic and international markets), Quality Management, Project Management (Clinical & Bioequivalence studies, CRAMS/CDMO/CTL studies), Partnership management (CRAMS, CDMO, CRO, CTL, CMO etc.) and other functional activities. Prior to joining Daewoong Pharmaceutical he served in multiple positions in various functions at Aurobindo Pharma Limited and Dr. Reddy’s Laboratories Limited, India.

Agenda Sessions

  • Interview: The CRO’s Approach to Clinical Pharma